These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1330580)

  • 21. Biological activities of human tumor necrosis factor-alpha and its novel mutants.
    Xi T; Shi X; Guo D; Dong X; Xu X; Zhu D
    Biochem Mol Biol Int; 1996 Apr; 38(4):855-62. PubMed ID: 8728116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production, isolation, and characterization of rabbit anti-idiotypic antibodies directed against human antithyrotrophin receptor antibodies.
    Baker JR; Lukes YG; Burman KD
    J Clin Invest; 1984 Aug; 74(2):488-95. PubMed ID: 6086714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral activity of tumor necrosis factor is signaled through the 55-kDa type I TNF receptor [corrected].
    Wong GH; Tartaglia LA; Lee MS; Goeddel DV
    J Immunol; 1992 Nov; 149(10):3350-3. PubMed ID: 1331233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptor in the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin.
    West DA; James NH; Cosulich SC; Holden PR; Brindle R; Rolfe M; Roberts RA
    Hepatology; 1999 Dec; 30(6):1417-24. PubMed ID: 10573520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxicity in L929 murine fibrosarcoma cells after triggering of transfected human p75 tumour necrosis factor (TNF) receptor is mediated by endogenous murine TNF.
    Vercammen D; Vandenabeele P; Declercq W; Van de Craen M; Grooten J; Fiers W
    Cytokine; 1995 Jul; 7(5):463-70. PubMed ID: 7578985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fas/Apo-1 activates nuclear factor kappa B and induces interleukin-6 production.
    Rensing-Ehl A; Hess S; Ziegler-Heitbrock HW; Riethmüller G; Engelmann H
    J Inflamm; 1995; 45(3):161-74. PubMed ID: 8597871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
    Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM
    Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor.
    Seckinger P; Zhang JH; Hauptmann B; Dayer JM
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5188-92. PubMed ID: 2164226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The biology of cachectin/TNF--a primary mediator of the host response.
    Beutler B; Cerami A
    Annu Rev Immunol; 1989; 7():625-55. PubMed ID: 2540776
    [No Abstract]   [Full Text] [Related]  

  • 30. Two TNF receptors.
    Tartaglia LA; Goeddel DV
    Immunol Today; 1992 May; 13(5):151-3. PubMed ID: 1322675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversed-phase high-performance liquid chromatographic tryptic digest peptide map comparisons of monoclonal antibodies to human tumor necrosis factor.
    Bloom JW
    J Chromatogr; 1992 Feb; 574(2):219-24. PubMed ID: 1618953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor.
    Tartaglia LA; Pennica D; Goeddel DV
    J Biol Chem; 1993 Sep; 268(25):18542-8. PubMed ID: 8395508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity.
    Engelmann H; Holtmann H; Brakebusch C; Avni YS; Sarov I; Nophar Y; Hadas E; Leitner O; Wallach D
    J Biol Chem; 1990 Aug; 265(24):14497-504. PubMed ID: 1696947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future.
    Sedger LM; McDermott MF
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):453-72. PubMed ID: 25169849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor necrosis factor/cachectin-induced modulation of endothelial cell hemostatic properties.
    Nawroth PP; Stern DM
    Onkologie; 1987 Aug; 10(4):254-8. PubMed ID: 2823200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour necrosis factor.
    Balkwill FR
    Br Med Bull; 1989 Apr; 45(2):389-400. PubMed ID: 2557114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level.
    Fiers W
    FEBS Lett; 1991 Jul; 285(2):199-212. PubMed ID: 1649771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody to tumor necrosis factor (TNF) reduces endotoxin fever.
    Nagai M; Saigusa T; Shimada Y; Inagawa H; Oshima H; Iriki M
    Experientia; 1988 Jul; 44(7):606-7. PubMed ID: 3396657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The common mediator of shock, cachexia, and tumor necrosis.
    Beutler B; Cerami A
    Adv Immunol; 1988; 42():213-31. PubMed ID: 2834923
    [No Abstract]   [Full Text] [Related]  

  • 40. Anti-idiotypic antibodies as probes of hormone receptor structure and function.
    Farid NR
    Methods Enzymol; 1989; 178():191-212. PubMed ID: 2481208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.